---
title: "Kengic grants 2 million restricted shares to 5 incentive recipients"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/231833404.md"
description: "According to the announcement from Kengic, the company has reviewed and approved the proposal on granting reserved restricted stocks to incentive objects. It has agreed to set March 14, 2025, as the reserved grant date, and will grant 2 million shares of the second category of restricted stocks at a grant price of 5.90 yuan per share to 5 incentive objects who meet the reserved grant conditions"
datetime: "2025-03-14T09:52:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/231833404.md)
  - [en](https://longbridge.com/en/news/231833404.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/231833404.md)
generator: "portal-rs"
---

# Kengic grants 2 million restricted shares to 5 incentive recipients

According to the announcement from Kengic (688455.SH), the company has approved the proposal on granting reserved restricted stocks to incentive objects. It has been agreed to set March 14, 2025, as the reserved grant date, with a grant price of 5.90 yuan per share, to grant 2 million shares of the second category of restricted stocks to 5 incentive objects who meet the reserved grant conditions

### Related Stocks

- [688455.CN](https://longbridge.com/en/quote/688455.CN.md)

## Related News & Research

- [Great Wall Motor sets self-exercise window for 18,074,310 stock options under 2023 incentive plan](https://longbridge.com/en/news/298208821.md)
- [Bosphoria Hair Announces 2026 Specialized Afro Hair Transplantation Focus in Istanbul](https://longbridge.com/en/news/298271512.md)
- [JLR plans 4,000 job cuts as tariffs sharpen its US push](https://longbridge.com/en/news/298224348.md)
- [M Stanley: Capital Injection Dilution for ICBC Milder Than Forecast; ABC Equity Dilution In Line](https://longbridge.com/en/news/298162976.md)
- [TAL: Production exceeds targets and new royalty terms improve future economics](https://longbridge.com/en/news/298178519.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**